A phase 2b/3 trial of saroglitazar in primary biliary cholangitis. Vuppalanchi R, Villamil A, Yilmaz Y, Idilman R, et al. Hepatology 2026 Oct 26. doi: 10.1097/HEP.0000000000001895.

Read + Share

Amedeo Smart

Independent Medical Education

Vuppalanchi R, Villamil A, Yilmaz Y, Idilman R, et al. A phase 2b/3 trial of saroglitazar in primary biliary cholangitis. Hepatology 2026 Oct 26. doi: 10.1097/HEP.0000000000001895.
PMID: 42929426